In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo

Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0026. Online ahead of print.ABSTRACTRoubille F, Bouabdallaoui N, Kouz S, et al. Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. 2024;47:467-470. 38181203.PMID:38710085 | DOI:10.7326/J24-0026

Source: Annals of Internal Medicine - May 6, 2024 Category: Internal Medicine Authors: Eric R Bates Source Type: research